Form 8-K - Current report:
SEC Accession No. 0001096906-24-000650
Filing Date
2024-03-28
Accepted
2024-03-28 14:06:15
Documents
15
Period of Report
2024-03-21
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 8-K SEC FILING tpia-20240321.htm   iXBRL 8-K 21440
2 LETTER FROM PINNACLE ACCOUNTANCY GROUP OF UTAH tpia_ex16z1.htm EX-16.1 3168
  Complete submission text file 0001096906-24-000650.txt   156991

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20240321_def.xml EX-101.DEF 1809
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20240321_lab.xml EX-101.LAB 20731
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20240321_pre.xml EX-101.PRE 13739
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20240321.xsd EX-101.SCH 2345
18 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20240321_htm.xml XML 2661
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56022 | Film No.: 24797564
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)